{"id":20323,"date":"2018-10-30T14:23:55","date_gmt":"2018-10-30T14:23:55","guid":{"rendered":"https:\/\/swiss-stem-cells-science.ch\/transplantation-of-blood-stem-cells-in-children\/"},"modified":"2024-03-13T10:14:52","modified_gmt":"2024-03-13T10:14:52","slug":"la-transplantation-cellules-souches-du-sang-chez-les-enfants","status":"publish","type":"post","link":"https:\/\/sscb-stembiotech.ch\/fr\/news\/la-transplantation-cellules-souches-du-sang-chez-les-enfants\/","title":{"rendered":"La transplantation de cellules souches du sang chez les enfants"},"content":{"rendered":"

Les enfants (0 \u2013 18 ans) se voient transplanter des cellules souches du sang en cas d\u2019immunod\u00e9ficience (29%), de maladie sanguine chronique (18%), de maladie m\u00e9tabolique (6%) ou de leuc\u00e9mie et de tumeur maligne (47%).<\/p>\n

Ces dix derni\u00e8res ann\u00e9es, 65% des enfants malades ont re\u00e7u des cellules de donneurs non apparent\u00e9s, 22% celles d\u2019un fr\u00e8re ou d\u2019une soeur HLA identique et les autres les cellules de leur p\u00e8re ou leur m\u00e8re haploidentique (13%).<\/p>\n

Les chances de gu\u00e9rison avec les cellules d\u2019un fr\u00e8re ou d\u2019une soeur ou d\u2019un donneur non apparent\u00e9 HLA identique se montent \u00e0 90%, sans tenir compte du risque de r\u00e9cidive des leuc\u00e9mies. Elles sont un peu inf\u00e9rieures avec les cellules d\u2019un donneur haploidentique mais ne cessent de s\u2019am\u00e9liorer. En Suisse, les transplantations de cellules souches du sang sur les enfants ont presque toujours lieu \u00e0 l\u2019H\u00f4pital p\u00e9diatrique de Zurich.<\/p>\n

Plus de d\u00e9tails en p. 6 du Magazine \u00ab\u00a0Together\u00a0\u00bb de Transfusion CRS Suisse: interview du professeur Tayfun G\u00fcng\u00f6r:
\nhttps:\/\/www.blutspende.ch\/fr\/cellules_souches_du_sang\/Actualites_sbsc\/fraichement-paru-together-ensemble-contre-la-leucemie\u20135<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Lire l\u2019article du magazine \u00ab Together \u00bb de Transfusion CRS Suisse.<\/p>\n","protected":false},"author":2,"featured_media":20318,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[102],"tags":[],"class_list":["post-20323","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-perspectives-therapeutiques"],"_links":{"self":[{"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/posts\/20323"}],"collection":[{"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/comments?post=20323"}],"version-history":[{"count":0,"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/posts\/20323\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/media\/20318"}],"wp:attachment":[{"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/media?parent=20323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/categories?post=20323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sscb-stembiotech.ch\/fr\/wp-json\/wp\/v2\/tags?post=20323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}